Literature DB >> 19379721

Multi-locus interactions of vascular homeostasis genes in essential hypertension: a gender-based study.

Rahul Kumar1, Azim Nejatizadeh, Ehtesham Arif, Salman Akhtar, Mohit Gupta, Sanjay Tyagi, A K Goyal, S K Jain, M A Qadar Pasha.   

Abstract

BACKGROUND: Studies on genes of endothelial and vascular homeostasis are inadequate in females.
METHODS: We investigated the role of 7 variants of ACE, AGT and NOS3 and their correlation with NO(x) levels and ACE activity in hypertension susceptibility in 910 case-controls of both genders.
RESULTS: Prevalence of alleles D of ACE I/D; -6A of AGT -6G/A; -786C, 894T and 4a of NOS3 -786T/C, 894G/T and 4b/4a polymorphisms was observed in patients (P< or =0.05). The 3 genotypes-combinations containing 6+5 wild-type alleles of AGT and NOS3 were significantly less prevalent in patients (P< or =0.0003). The haplotypes 235T/174T/-6A of AGT (P=4E-3) and -786T/894G/4a and -786C/894G/4a of NOS3 (P=2E-3, P=0.011, respectively) were significantly more prevalent in patients. The AGT and NOS3 findings were similar in males. Genotypes-combinations with 6+5 wild-type alleles of AGT correlated with higher NO(x) levels (P=0.03). The NOS3 genotypes-combinations having 6 and 6+5 wild-type alleles correlated with decreased ACE activity (P=0.025, P=0.0015, respectively) and increased NO(x) levels (P=0.001, P=0.0001, respectively) in patients. In gene-gene interactions, ACE D allele associated with < or =4 wild-type alleles containing genotypes-combinations of AGT and NOS3 in patients (P< or =0.04).
CONCLUSION: Within gene and between genes interactions of variants influence ACE activity and NO(x) levels and associate with EH.

Entities:  

Mesh:

Year:  2009        PMID: 19379721     DOI: 10.1016/j.cca.2009.04.010

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  CYBA (p22phox) variants associate with blood pressure and oxidative stress markers in hypertension: a replication study in populations of diverse altitudes.

Authors:  Rahul Kumar; Samantha Kohli; Zahara Ali; Kanika Duhan; Rekhbala Ram; Mohit Gupta; Sanjay Tyagi; Ghulam Mohammad; Ma Qadar Pasha
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

2.  Impact of interactions between risk alleles on clinical endpoints in hypertension.

Authors:  Samantha Kohli; Rahul Kumar; Mohit Gupta; Sanjay Tyagi; M A Qadar Pasha
Journal:  Heart Asia       Date:  2016-05-19

3.  Cardiovascular consequences of genetic variation at -6/235 in human angiotensinogen using "humanized" gene-targeted mice.

Authors:  Justin L Grobe; Matthew E Dickson; Sungmi Park; Deborah R Davis; Ella J Born; Curt D Sigmund
Journal:  Hypertension       Date:  2010-09-07       Impact factor: 10.190

4.  Using reduced rule base with Expert System for the diagnosis of disease in hypertension.

Authors:  Fatih Başçiftçi; Ayşe Eldem
Journal:  Med Biol Eng Comput       Date:  2013-09-17       Impact factor: 2.602

5.  An NOS3 Haplotype is Protective against Hypertension in a Caucasian Population.

Authors:  Georgios D Kitsios; Elias Zintzaras
Journal:  Int J Hypertens       Date:  2010-03-25       Impact factor: 2.420

Review 6.  Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women.

Authors:  Flavia Franconi; Ilaria Campesi
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

7.  Female-specific hypertension loci on rat chromosome 13.

Authors:  Matthew J Hoffman; Michael J Flister; Lizbeth Nunez; Bing Xiao; Andrew S Greene; Howard J Jacob; Carol Moreno
Journal:  Hypertension       Date:  2013-07-01       Impact factor: 10.190

Review 8.  Vascular homeostasis at high-altitude: role of genetic variants and transcription factors.

Authors:  Neha Chanana; Tsering Palmo; John H Newman; M A Qadar Pasha
Journal:  Pulm Circ       Date:  2020-11-19       Impact factor: 3.017

Review 9.  Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19.

Authors:  Rahul Kumar; Michael H Lee; Claudia Mickael; Biruk Kassa; Qadar Pasha; Rubin Tuder; Brian Graham
Journal:  ERJ Open Res       Date:  2020-12-07

Review 10.  Does eNOS derived nitric oxide protect the young from severe COVID-19 complications?

Authors:  Shou Ping Guan; Raymond Chee Seong Seet; Brian K Kennedy
Journal:  Ageing Res Rev       Date:  2020-11-04       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.